Sinil Pharmaceutical Financials
| 012790 Stock | KRW 6,510 10.00 0.15% |
Sinil |
Understanding current and past Sinil Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sinil Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Sinil Pharmaceutical's assets may result in an increase in income on the income statement.
Please note, the presentation of Sinil Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sinil Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sinil Pharmaceutical's management manipulating its earnings.
Sinil Pharmaceutical Stock Summary
Sinil Pharmaceutical competes with Kolon Life, JETEMA, Aminologics CoLtd, HLB Pharmaceutical, and Withuspharmaceutical. Sinil Pharmaceutical Co., Ltd. manufactures, markets, and sells pharmaceutical products in South Korea. Sinil Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea. Shinil Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7012790002 |
| Business Address | 5 1 Sanjeonjangsu |
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | www.sinilpharm.com |
| Phone | (82) 43 855 3944 |
| Currency | KRW - South Korean Won |
You should never invest in Sinil Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sinil Stock, because this is throwing your money away. Analyzing the key information contained in Sinil Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sinil Pharmaceutical Key Financial Ratios
Sinil Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Sinil Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Sinil Pharmaceutical over time and compare it to other companies across industries.| Return On Equity | 9.59 | |||
| Return On Asset | 0.0247 | |||
| Target Price | 20300.0 | |||
| Number Of Employees | 13 | |||
| Beta | 1.85 |
Sinil Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sinil Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Sinil Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sinil Pharmaceutical competition to find correlations between indicators driving Sinil Pharmaceutical's intrinsic value. More Info.Sinil Pharmaceutical Co is rated second in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The ratio of Return On Equity to Return On Asset for Sinil Pharmaceutical Co is about 388.12 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sinil Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sinil Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sinil Pharmaceutical Systematic Risk
Sinil Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sinil Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sinil Pharmaceutical correlated with the market. If Beta is less than 0 Sinil Pharmaceutical generally moves in the opposite direction as compared to the market. If Sinil Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sinil Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sinil Pharmaceutical is generally in the same direction as the market. If Beta > 1 Sinil Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Sinil Pharmaceutical February 6, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sinil Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sinil Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sinil Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Sinil Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sinil Pharmaceutical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 7.64 | |||
| Value At Risk | (2.96) | |||
| Potential Upside | 3.54 |
Complementary Tools for Sinil Stock analysis
When running Sinil Pharmaceutical's price analysis, check to measure Sinil Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinil Pharmaceutical is operating at the current time. Most of Sinil Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinil Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinil Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinil Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |